Holen Sie sich die Stockscreener-App
6.445
0.36%
-0.025
Schlusskurs vom Vortag:
$6.47
Offen:
$6.47
24-Stunden-Volumen:
961.78K
Relative Volume:
0.52
Marktkapitalisierung:
$1.31B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-19.53
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
+10.96%
1M Leistung:
+63.21%
6M Leistung:
+170.87%
1J Leistung:
+81.09%
1-Tages-Spanne:
$6.40
$6.64
1-Wochen-Bereich:
$5.82
$6.78
52-Wochen-Spanne:
$1.89
$6.78
Savara Inc Stock (SVRA) Company Profile
Firmenname
Savara Inc
Sektor
Branche
Telefon
51285113796
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Vergleichen Sie SVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
6.425 | 1.32B | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.54 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.32 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.88 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
892.74 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.73 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-13 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-07 | Eingeleitet | Guggenheim | Buy |
| 2023-05-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-03-16 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-15 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Fortgesetzt | ROTH Capital | Neutral |
| 2018-01-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-09-27 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-22 | Eingeleitet | Jefferies | Buy |
| 2017-09-11 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Savara Inc Aktie (SVRA) Neueste Nachrichten
Certain Warrants of Savara Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com
172,836,922 Common Stock of Savara Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com
Savara stock hits 52-week high at 6.61 USD By Investing.com - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Savara (NASDAQ:SVRA) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Affinity Asset Advisors LLC Purchases New Stake in Savara Inc. $SVRA - MarketBeat
Savara issues patent for Molbreevi from European Patent Office - MSN
Savara rumor highlighted in Betaville blog - MSN
How strong dollar benefits Savara Inc. (YB4P) stock2025 Market WrapUp & Low Drawdown Investment Ideas - Newser
Dir Elam Acquires 4,387 Of Savara Inc [SVRA] - TradingView
Savara Inc. (SVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Savara Inc. (YB4P) stock supported by free cash flowDip Buying & Daily Price Action Insights - Newser
Savara (NASDAQ:SVRA) Shares Up 6.8%What's Next? - MarketBeat
Savara (SVRA) Stock Analysis Report | Financials & Insights - Benzinga
Savara (NASDAQ:SVRA) Reaches New 1-Year HighShould You Buy? - MarketBeat
Will Savara Inc. (YB4P) stock boost dividends furtherWeekly Trade Recap & Breakout Confirmation Alerts - Newser
Is Savara Inc. stock trading near support levelsRecession Risk & AI Optimized Trade Strategies - Newser
Is Savara Inc. (YB4P) stock a top pick for value investorsEarnings Recap Summary & High Return Stock Watch Alerts - Newser
Savara (NASDAQ:SVRA) Nasdaq Today Specialized Biotech Direction - Kalkine Media
Savara Inc. ticks higher amid takeover speculation - MSN
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System - BioSpace
Savara receives European patent for PAP treatment device By Investing.com - Investing.com Canada
Why analysts upgrade Savara Inc. stockTrade Volume Summary & Weekly High Return Forecasts - Newser
Savara to Spotlight Lead Therapy in Fireside Chats at Major Healthcare Conferences - MSN
Savara Inc. (SVRA) Rises Amid Takeover Speculation - GuruFocus
Savara (SVRA) Market Activity Stirred by Acquisition Rumor - GuruFocus
Savara Inc. ticks higher amid takeover speculation (SVRA:NASDAQ) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Savara (NASDAQ:SVRA) Shares Gap DownHere's Why - MarketBeat
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Deliver - PharmiWeb.com
Savara, PARI Granted European Patent Covering Drug-Device Combination - marketscreener.com
Savara (SVRA) Secures European Patent for Drug-Device Combo - GuruFocus
Savara receives European patent for PAP treatment device - Investing.com
Is Savara Inc. (YB4P) stock a top hedge fund pickBull Run & Verified Stock Trade Ideas - Newser
Savara (SVRA) Climbs 27.8% Ahead of 2 Health Conferences - Finviz
F m Investments LLC Acquires 91,830 Shares of Savara Inc. $SVRA - MarketBeat
10 Small Caps With Big Double-Digit Gains - Insider Monkey
Savara to Resubmit BLA for Rare Lung Disease Treatment as Losses Widen in Q2 - MSN
Savara Stock Surges Amid Positive Financial Developments and Raised Price Target - timothysykes.com
Savara Inc. Sees Price Target Raised Amid Promising Drug Developments - StocksToTrade
Savara Inc’s Stock Boosted by Strategic Financial Moves and Developments - StocksToTrade
Savara’s Strategic Moves Strengthen Market Position with Price Target Increase - timothysykes.com
Savara Stock: Will It Continue to Rise? - StocksToTrade
Savara Inc. (SVRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Savara Inc (SVRA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Savara Inc stock hits 52-week high at 5.51 USD By Investing.com - Investing.com Nigeria
Savara Inc stock hits 52-week high at 5.51 USD - Investing.com
Finanzdaten der Savara Inc-Aktie (SVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):